GAMP 5 update: computerized system expectations for pharma manufacturers
European Pharmaceutical Review
NOVEMBER 15, 2022
As ISPE GAMP 5 Second Edition notes in the preface “Operating in a highly regulated industry may lead practitioners to apply prescriptive and rigid compliance-based approaches that are not commensurate with and not effective in managing any actual risk to the product and the patient.”
Let's personalize your content